Puma Biotechnology, Inc.
PBYINASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $570.67M
- P/E (TTM)
- 21.69
- Forward P/E
- 39.34
- Dividend yield
- -
- 52-week range
- $4.58$10.84
- Volume (live)
- -
- Avg. volume (3M)
- 348.10K
Puma Biotechnology (PBYI) Stock Price & Financial Analysis
Puma Biotechnology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.73 - $11.32 |
|---|---|
| 52-Week High | $10.84 |
| 52-Week Low | $4.58 |
| Open | $11.11 |
| Volume (last close) | 355.69K |
| Average Volume (3M) | 348.10K |
| Revenue (TTM) | 231.24M |
|---|---|
| Net Income (TTM) | 26.72M |
| Free Cash Flow (TTM) | 41.14M |
| EPS (TTM) | $0.52 |
| Profit Margin | 11.55% |
| Operating Margin | 13.16% |
| Return on Equity (ROE) | 19.28% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 570.67M |
|---|---|
| Shares Outstanding | 52.60M |
| P/E Ratio (TTM) | 21.69 |
| Forward P/E | 39.34 |
| Price to Sales (P/S) | 2.51 |
| Price to Book (P/B) | 4.18 |
| EV/EBITDA | 12.67 |
| 50-Day MA | $9.52 |
|---|---|
| 200-Day MA | $7.73 |
| 1-Year Change | +123.41% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Puma Biotechnology at a Glance
As of the Oct 26, 2026 close, Puma Biotechnology (PBYI) has a market capitalization of $570.67M. The stock trades at 21.7× trailing earnings, 39.3× forward earnings and 2.5× sales. Over the trailing twelve months it earned $26.72M on revenue of $231.24M (a 11.6% profit margin) and generated $41.14M of free cash flow. Revenue fell 2.9% year over year.
As of its latest reported balance sheet, it holds $36.54M in cash and securities against $4.82M of debt, a net cash position of $31.72M.
Puma Biotechnology does not currently pay a dividend.
The share price is up 123.4% over the past year. At $10.85 (the Oct 26, 2026 close) it sits near the top of its 52-week range of $4.58 to $10.84, above its 200-day moving average of $7.73.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Puma Biotechnology
What is the current stock price for PBYI?
As of the Oct 26, 2026 close, PBYI stock trades at $10.85. The 52-week range is $4.58–$10.84, with a day range of $10.73–$11.32.
What is the P/E ratio for PBYI?
As of the Oct 26, 2026 close, Puma Biotechnology's trailing twelve-month (TTM) P/E ratio is 21.7, meaning investors pay $21.7 for every $1 of annual earnings. The forward P/E is 39.3, reflecting analyst expectations for future earnings. Puma Biotechnology operates in the Healthcare sector.
Does PBYI pay dividends?
Puma Biotechnology does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for PBYI?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for PBYI is Hold.
What is the market cap of PBYI?
As of the Oct 26, 2026 close, Puma Biotechnology's market capitalization is $570.7M, classifying it as a small-cap company. Puma Biotechnology operates in the Healthcare sector within the Biotechnology industry.